ETFMG Treatments, Testing and Advancements ETF (GERM) — ETF Analysis on Winston

Key Facts

• Issuer: Amplify
• Category: Equity
• Asset Class: Equity
• Price: $19.16
• Expense Ratio: 68.00%
• Assets Under Management: $10M
• Number of Holdings: 57
• Inception Date: 2020-06-18
• Currency: USD

Winston Score

ETFMG Treatments, Testing and Advancements ETF has a Winston Score of 48 out of 100.

Top Holdings

Alnylam Pharmaceuticals Inc (N/A%), Labcorp Holdings Inc (N/A%), Quest Diagnostics Inc (N/A%), BioNTech SE (N/A%), Bio-Rad Laboratories Inc (N/A%)

Sector Breakdown

Cash & Others (N/A%), Financial Services (N/A%), Healthcare (N/A%)